Molecule - About the company
Molecule is a series B company based in Houston (United States), founded in 2012 by Sameer Soleja. It operates as a SaaS-based platform for commodity trading. Molecule has raised $26.2M in funding from investors like Mercury Fund, Surge Ventures and Sundance Growth. The company has 966 active competitors, including 168 funded and 104 that have exited. Its top competitors include companies like Cytora, Shift Technology and OpenGamma.
Company Details
Molecule provides a SaaS-based platform for commodity trading. It calculates position and risk for companies that trade commodity futures, forwards, options, and swaps. It supports electricity, natural gas, crude oil, NGLs, and many other commodities worldwide. Molecule downloads trades from exchanges, automatically brings in market data from Morningstar, and computes companies' daily or real-time analyses instantly.
- Website
- molecule.io
- Email ID
- *****@molecule.io
- Phone Number
- +1 **********
- Registered Address
- Houston, Texas
Key Metrics
Founded Year
2012
Location
Houston, United States
Stage
Series B
Total Funding
$26.2M in 5 rounds
Latest Funding Round
Investors
Ranked
14th among 966 active competitors
Employee Count
48 as on Apr 30, 2026
Legal entities associated with Molecule
Molecule is associated with 2 legal entities given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Documents |
|---|---|---|---|---|
MOLECULE SOFTWARE, INC. CIN: 900863168 , United States, Active | Dec 31, 1999 | - | 28 (As on Dec 31, 2024) | - |
Molecule Software, Inc. CIN: 20181662878 , United States, Active | Aug 23, 2018 | - | - | - |
Sign up to download Molecule's company profile
Molecule's funding and investors
Molecule has raised a total funding of $26.2M over 5 rounds. Its first funding round was on May 24, 2012. Its latest funding round was a Series B round on Jul 14, 2025 for $*****. 1 investor participated in its latest round. Molecule has 4 institutional investors.
Here is the list of recent funding rounds of Molecule:
Filter this list
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Jul 14, 2025 | 4464958 | Series B | 1658447 | 9151841 | 5737495 | 3716601 |
May 06, 2021 | 5276400 | Series A | 9623869 | 4246648 | 4729733 | 8234878 |
Nov 2014 | 3906246 | Seed | 1501580 | 7406353 | 9816674 |
View details of Molecule's funding rounds and investors
Molecule's founders and board of directors
Founder? Claim ProfileThe founders of Molecule is Sameer Soleja. Sameer Soleja is the CEO of Molecule.
Here are the details of Molecule's key team members:
- Sameer Soleja: Founder & CEO of Molecule.
View details of Molecule's Founder profiles and Board Members
Molecule's employee count trend
Molecule has 48 employees as of Apr 26. Here is Molecule's employee count trend over the years:
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Molecule's Competitors and alternates
Top competitors of Molecule include Cytora, Shift Technology and OpenGamma. Here is the list of Top 10 competitors of Molecule, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Cytora 2012, London (United Kingdom), Acquired | Risk management solutions for insurers and underwriters | $41.5M | 69/100 | |
2nd | Shift Technology 2014, Paris (France), Series D | Provider of AI solutions for insurance underwriting, claims, and risk | $320M | 67/100 | |
3rd | OpenGamma 2009, London (United Kingdom), Acquired | Platform that provides SaaS based solutions for derivatives risk analytics | $74.9M | 66/100 | |
4th | Platform offering insurance risk management solutions | - | 65/100 | ||
5th | CoreLogic 1894, Irvine (United States), Acquired | Provider of property data, analytics, and workflow solutions for various industries | - | 65/100 | |
6th | Credit Benchmark 2012, London (United Kingdom), Series B | Credit risk data aggregator of banks | $35.6M | 65/100 | |
7th | Provider of an AI platform for data and analytics solutions | $16.3M | 65/100 | ||
8th | T-REX Group 2012, New York City (United States), Acquired | Financial SaaS platform for renewable industry | $77.2M | 64/100 | |
9th | Evident 2016, Wilmington (United States), Series C | Online identity verification and customer PII data security and privacy | $44.3M | 64/100 | |
10th | Access Fintech 2016, New York City (United States), Series C | Risk management solutions for financial institutions | $97.5M | 63/100 | |
14th | Molecule 2012, Houston (United States), Series B | SaaS-based platform for commodity trading | $26.2M | 61/100 |
Looking for more details on Molecule's competitors? Click here to see the top ones
Molecule's Investments and acquisitions
Molecule has made no investments or acquisitions yet.
Reports related to Molecule
Here is the latest report on Molecule's sector:
News related to Molecule
Media has covered Molecule for a total of 4 events in the last 1 year, 1 of them has been about company updates.
•
•
•
Sundance Growth Invests in Molecule for Energy Trading TechnologyPR Newswire•Jul 16, 2025•Molecule, Sundance Growth
•
Nuveen Selects Molecule Software’s ETRM to Scale Renewable Trading Capabilitiesctrmcenter.com•Jun 12, 2025•Nuveen, Molecule
•
•
•
WGL Energy Selects Molecule's ETRM Platform for Managing Gas, Power, and RenewablesPR Newswire•Sep 27, 2023•WGL Energy, Molecule
•
•
Molecule Launches New Environment in Europe for Growing Number of UK and EU CustomersPR Newswire•Mar 14, 2023•Molecule
•
Are you a Founder ?
FAQs about Molecule
Explore our recently published companies
- WealthStream - New York City based, 2025 founded, Unfunded company
- Prammanadi - Mayiladuthurai based, 2001 founded, Unfunded company
- Relentless - San Francisco based, 2025 founded, Unfunded company